The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy

Alexandra Calmy¹, Nathan Ford², Graeme Meintjes^{3

4}

Affiliations

¹ Division of Infectious Diseases, HIV Unit, Department of Internal Medicine Specialties, Geneva University Hospitals and Faculty of Medicine.
² Department of HIV, World Health Organization, Geneva, Switzerland.
³ Wellcome Trust Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine.
⁴ Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.

Alexandra Calmy et al. Clin Infect Dis. 2018.

. 2018 Mar 4;66(suppl_2):S103-SS105.

doi: 10.1093/cid/cix1138.

Alexandra Calmy¹, Nathan Ford², Graeme Meintjes^{3

4}

¹ Division of Infectious Diseases, HIV Unit, Department of Internal Medicine Specialties, Geneva University Hospitals and Faculty of Medicine.
² Department of HIV, World Health Organization, Geneva, Switzerland.
³ Wellcome Trust Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine.
⁴ Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.

No abstract available

Figures

1. Carmona S, Bor J, Nattey C et al. . Persistent high burden of advanced human immunodeficiency virus (HIV) disease among patients seeking care in South Africa’s national HIV program: data from a nationwide laboratory cohort. Clin Infect Dis 2018;66:S111–7. - PMC - PubMed
1. Osler M, Hilderbrand K, Goemaere E et al. The continuing burden of advanced HIV disease over 10 years of increasing antiretroviral therapy coverage in South Africa. Clin Infect Dis 2018;66:S118–25. - PMC - PubMed
1. Ousley J, Niyibizi A, Wanjala S et al. . High proportions of patients with advanced human immunodeficiency virus are antiretroviral therapy experienced: hospitalization outcomes from 2 sub-Saharan African sites. Clin Infect Dis 2018;66:S126–32. - PMC - PubMed
1. IeDEA and COHERE Cohort Collaborations. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clin Infect Dis 2018; Jan 25. - PMC - PubMed
1. Bisson GP, Ramchandani R, Miyahara S et al. . Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults. AIDS 2017; 31:2217–25. - PMC - PubMed